MASS Stock Analysis: Buy, Sell, or Hold?
MASS - 908 Devices Inc. Common Stock
$5.75
-0.03 (-0.52%)
โผ
5d:
-5.89%
30d:
-16.67%
90d:
+6.28%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When MASS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
๐ HOLD: MASS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
๐ HOLD: MASS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MASS is currently trading at $5.75, which is considered oversold relative to its 30-day fair value range of $6.02 to $6.71.
Technical Outlook: Technically, MASS is showing sideways momentum. The price is currently testing key support at $5.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.00 (+73.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MASS is showing sideways momentum. The price is currently testing key support at $5.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.00 (+73.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.02 -
$6.71
Company Quality Score
48/100
(HOLD)
Options IV Signal
11th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 11th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 73.9% below Wall St target ($10.00)
- CAUTION: Recommendation downgraded due to -5.9% 5-day decline
Fair Price Analysis
30-Day Fair Range
$6.02 -
$6.71
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
ยฑ$0.87
(15.2%)
Support & Resistance Levels
Support Level
$5.70
Resistance Level
$6.52
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.49
Wall Street Target
$10.00
(+73.9%)
Revenue Growth (YoY)
-7.7%
Profit Margin
34.7%
Share & Embed Analysis
Last updated: March 30, 2026 5:59 PM ET
Data refreshes hourly during market hours. Next update: 6:59 PM
Data refreshes hourly during market hours. Next update: 6:59 PM
๐ฅ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MASS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph H Iv Griffith
SELL
23175 shares
2026-02-02
Joseph H Iv Griffith
SELL
4292 shares
2025-10-03
Joseph H Iv Griffith
SELL
708 shares
2025-10-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 50 HOLD |
|
GEHC
GE HealthCare Technologiโฆ |
STRONG BUY
21 analysts |
$93 | 59 HOLD |